India, Nov. 21 -- image credit- pib

The Technology Development Board (TDB), Department of Science & Technology, Government of India, has sanctioned financial support to Mumbai-based startup TechInvention Lifecare for the establishment of a commercial-scale cGMP facility for the production of an indigenously developed 16-valent Pneumococcal Conjugate Vaccine (PCV-16).

The supported project aims to strengthen India's capability in next-generation conjugate vaccines and reduce long-term dependence on imported products through domestic innovation and manufacturing.

The PCV-16 technology is built on a strategically selected panel of 16 pneumococcal serotypes, representing strains most associated with invasive pneumococcal disease (IPD), ant...